Search Match Terms (12)

Recruiting

A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors

Pediatric Solid Tumors
|
Pediatric Cancer
Enter your postal code
to see sites near you
Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Pediatric Crohn's Disease
|
Pediatric Ulcerative Colitis
Enter your postal code
to see sites near you
Recruiting

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Pediatric Solid Tumors
|
Pediatric Cancer
Enter your postal code
to see sites near you
Recruiting

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Pediatric Solid Tumors
|
Pediatric Cancer
Enter your postal code
to see sites near you
Recruiting

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis (BREEZE-AD-PEDS)

Pediatric Atopic Dermatitis (Eczema)
Enter your postal code
to see sites near you
Recruiting

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Pediatric Uveitis
Enter your postal code
to see sites near you
Recruiting

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

Pediatric Migraine
Enter your postal code
to see sites near you
Recruiting

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

Pediatric Migraine
Enter your postal code
to see sites near you
Recruiting

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-1)

Pediatric Crohn's Disease
Enter your postal code
to see sites near you
Recruiting

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

Pediatric Migraine
Enter your postal code
to see sites near you
Recruiting

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

Pediatric Migraine
Enter your postal code
to see sites near you
Recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Pediatric Type 2 Diabetes
Enter your postal code
to see sites near you
Recruiting

A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes (RescuiNGkids)

Pediatric Type 1 Diabetes
Enter your postal code
to see sites near you
Recruiting

A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER-PEDS)

Pediatric COVID-19 (Coronavirus)
Enter your postal code
to see sites near you
Not the right fit? Sign up to receive updates on new trials.
Not yet recruiting

A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

Pediatric Atopic Dermatitis (Eczema)
Enter your postal code
to see sites near you
Not yet recruiting

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Pediatric Atopic Dermatitis (Eczema)
Enter your postal code
to see sites near you
Active not recruiting

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Pediatric Solid Tumors
|
Pediatric Cancer
Enter your postal code
to see sites near you
Active not recruiting

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

Pediatric Atopic Dermatitis (Eczema)
Enter your postal code
to see sites near you
Active not recruiting

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate2)

Pediatric Atopic Dermatitis (Eczema)
Enter your postal code
to see sites near you
Active not recruiting

Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis (ADore)

Pediatric Atopic Dermatitis (Eczema)
Enter your postal code
to see sites near you
Active not recruiting

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (ADhere-J)

Pediatric Atopic Dermatitis (Eczema)
Enter your postal code
to see sites near you
Active not recruiting

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) (SHINE1)

Pediatric Ulcerative Colitis
Enter your postal code
to see sites near you